Company profile
Optimi Health Corp.
NASDAQ:OPTHBiotechnology: Pharmaceutical Preparations
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT05252598 | — | withdrawn | 2023-01-01 | 2023-08-01 | Optimi Health Corporation | Mood and Cognitive Effects of Psilocybin in Healthy Participants |
FDA applications (0)
No records yet.